Biomarkers and Precision Oncology Forum shared a post on LinkedIn:
“Agnostic Molecular Tumor Board — BPOF 2026
A landmark interactive segment of BPOF 2026, the Agnostic Molecular Tumor Board convenes leading oncologists, molecular pathologists, and precision medicine specialists to deliberate complex cases through a tumour-agnostic lens — where the molecular profile, not the organ of origin, guides clinical decision-making.
Moderator: Dr. Nitesh Rohatgi (India)
Panelists:
- Dr. Aparna Dhar (India)
- Dr. Chiang Jianbang (Singapore)
- Dr. Jason Chan (Singapore)
- Dr. Tan Ya Hwee (Singapore)
30 July 2026
Academia, Singapore
10:05 – 10:30 HRS (SGT)
CME Accredited
Because in precision oncology, the molecule often speaks louder than the map.
Other articles about BPOF on OncoDaily.